Sökning: WFRF:(Amos K.) > Obesity, metabolic ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 09578naa a2201129 4500 | |
001 | oai:DiVA.org:umu-137383 | |
003 | SwePub | |
008 | 170706s2017 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:c57d2208-8a7c-4b90-a329-db261e03f196 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1373832 URI |
024 | 7 | a https://doi.org/10.1371/journal.pone.01778752 DOI |
024 | 7 | a https://lup.lub.lu.se/record/c57d2208-8a7c-4b90-a329-db261e03f1962 URI |
040 | a (SwePub)umud (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Carreras-Torres, Robertu International Agency for Research on Cancer, World Health Organization4 aut |
245 | 1 0 | a Obesity, metabolic factors and risk of different histological types of lung cancer :b a Mendelian randomization study |
264 | c 2017-06-08 | |
264 | 1 | b Public library science,c 2017 |
338 | a electronic2 rdacarrier | |
520 | a Background: Assessing the relationship between lung cancer and metabolic conditions is challenging because of the confounding effect of tobacco. Mendelian randomization (MR), or the use of genetic instrumental variables to assess causality, may help to identify the metabolic drivers of lung cancer. Methods and findings: We identified genetic instruments for potential metabolic risk factors and evaluated these in relation to risk using 29,266 lung cancer cases (including 11,273 adenocarcinomas, 7,426 squamous cell and 2,664 small cell cases) and 56,450 controls. The MR risk analysis suggested a causal effect of body mass index (BMI) on lung cancer risk for two of the three major histological subtypes, with evidence of a risk increase for squamous cell carcinoma (odds ratio (OR) [95% confidence interval (CI)] = 1.20 [1.01-1.43] and for small cell lung cancer (OR [95% CI] = 1.52 [1.15-2.00]) for each standard deviation (SD) increase in BMI [4.6 kg/m(2)]), but not for adenocarcinoma (OR [95% CI] = 0.93 [0.79-1.08]) (P-heterogeneity = 4.3x10(-3)). Additional analysis using a genetic instrument for BMI showed that each SD increase in BMI increased cigarette consumption by 1.27 cigarettes per day (P = 2.1x10(-3)), providing novel evidence that a genetic susceptibility to obesity influences smoking patterns. There was also evidence that low-density lipoprotein cholesterol was inversely associated with lung cancer overall risk (OR [95% CI] = 0.90 [0.84-0.97] per SD of 38 mg/dl), while fasting insulin was positively associated (OR [95% CI] = 1.63 [1.25-2.13] per SD of 44.4 pmol/l). Sensitivity analyses including a weighted-median approach and MR-Egger test did not detect other pleiotropic effects biasing the main results. Conclusions: Our results are consistent with a causal role of fasting insulin and low-density lipoprotein cholesterol in lung cancer etiology, as well as for BMI in squamous cell and small cell carcinoma. The latter relation may be mediated by a previously unrecognized effect of obesity on smoking behavior. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
700 | 1 | a Johansson, Mattiasu International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Haycock, Philip C.u University of Bristol,Fred Hutchinson Cancer Research Center4 aut |
700 | 1 | a Wade, Kaitlin H.u University of Bristol4 aut |
700 | 1 | a Relton, Caroline L.u University of Bristol4 aut |
700 | 1 | a Martin, Richard M.u University of Bristol4 aut |
700 | 1 | a Smith, George Daveyu University of Bristol4 aut |
700 | 1 | a Albanes, Demetriusu National Cancer Institute, USA4 aut |
700 | 1 | a Aldrich, Melinda C.u Vanderbilt University4 aut |
700 | 1 | a Andrew, Angelineu Norris Cotton Cancer Center,Dartmouth College,University of Liverpool,Radboud University Medical Center4 aut |
700 | 1 | a Arnold, Susanne M.u University of Kentucky4 aut |
700 | 1 | a Bickeböller, Heikeu University of Göttingen4 aut |
700 | 1 | a Bojesen, Stig E.u University of Copenhagen4 aut |
700 | 1 | a Brunnström, Hansu Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Regional Laboratories Region Skåne4 aut0 (Swepub:lu)med-hsb |
700 | 1 | a Manjer, Jonasu Lund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups,Regional Laboratories Region Skåne4 aut0 (Swepub:lu)smi-jma |
700 | 1 | a Brüske, Ireneu Helmholtz Zentrum München4 aut |
700 | 1 | a Caporaso, Neil E.u National Cancer Institute, NCI4 aut |
700 | 1 | a Chen, Chuu Harvard T.H. Chan School of Public Health,Harvard Medical School4 aut |
700 | 1 | a Christiani, David C.4 aut |
700 | 1 | a Christian, W. Jayu University of Kentucky4 aut |
700 | 1 | a Doherty, Jennifer A.4 aut |
700 | 1 | a Duell, Eric J.u Catalan Institute of Oncology4 aut |
700 | 1 | a Field, John K.u University of Liverpool4 aut |
700 | 1 | a Davies, Michael P. A.4 aut |
700 | 1 | a Marcus, Michael W.u University of Liverpool4 aut |
700 | 1 | a Goodman, Gary E.u Fred Hutchinson Cancer Research Center4 aut |
700 | 1 | a Grankvist, Kjellu Umeå University,Umeå universitet,Klinisk kemi4 aut0 (Swepub:umu)kjgr0002 |
700 | 1 | a Haugen, Aageu National Institute of Occupational Health, Norway4 aut |
700 | 1 | a Hong, Yun-Chulu Seoul National University4 aut |
700 | 1 | a Kiemeney, Lambertus A.4 aut |
700 | 1 | a van der Heijden, Erik H. F. M.u Radboud University Medical Center4 aut |
700 | 1 | a Kraft, Peteru Harvard T.H. Chan School of Public Health4 aut |
700 | 1 | a Johansson, Mikael B.u Umeå University,Umeå universitet,Onkologi4 aut0 (Swepub:umu)mijo0025 |
700 | 1 | a Lam, Stephenu British Columbia Cancer Agency4 aut |
700 | 1 | a Landi, Maria Teresau National Cancer Institute, USA4 aut |
700 | 1 | a Lazarus, Philipu Washington State University College of Pharmacy4 aut |
700 | 1 | a Le Marchand, Loïcu University of Hawaii Cancer Center4 aut |
700 | 1 | a Liu, Geoffreyu Princess Margaret Hospital University of Toronto4 aut |
700 | 1 | a Melander, Olleu Lund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Kardiovaskulär forskning - hypertoni,Forskargrupper vid Lunds universitet,Department of Clinical Sciences, Malmö,Faculty of Medicine,Cardiovascular Research - Hypertension,Lund University Research Groups,Skåne University Hospital4 aut0 (Swepub:lu)endo-ome |
700 | 1 | a Park, Sungshim L.u University of Southern California4 aut |
700 | 1 | a Rennert, Gadu Technion - Israel Institute of Technology4 aut |
700 | 1 | a Risch, Angelau University of Salzburg4 aut |
700 | 1 | a Haura, Eric B.u H. Lee Moffitt Cancer Center & Research Institute4 aut |
700 | 1 | a Scelo, Ghislaineu International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Zaridze, Davidu N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences4 aut |
700 | 1 | a Mukeriya, Anushu N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences4 aut |
700 | 1 | a Savić, Milanu Clinical Center of Serbia4 aut |
700 | 1 | a Lissowska, Jolantau The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology4 aut |
700 | 1 | a Swiatkowska, Beatau Nofer Institute of Occupational Medicine4 aut |
700 | 1 | a Janout, Vladimiru University of Ostrava4 aut |
700 | 1 | a Holcatova, Ivanau Charles University in Prague4 aut |
700 | 1 | a Mates, Danau National Institute of Public Health, Romania4 aut |
700 | 1 | a Schabath, Matthew B.u H. Lee Moffitt Cancer Center & Research Institute4 aut |
700 | 1 | a Shen, Hongbingu Nanjing Medical University4 aut |
700 | 1 | a Tardon, Adoninau University of Oviedo4 aut |
700 | 1 | a Teare, Dawnu University of Sheffield4 aut |
700 | 1 | a Woll, Penellau University of Sheffield4 aut |
700 | 1 | a Tsao, Ming-Soundu Princess Margaret Hospital University of Toronto4 aut |
700 | 1 | a Wu, Xifengu University of Texas4 aut |
700 | 1 | a Yuan, Jian-Minu University of Pittsburgh Cancer Institute4 aut |
700 | 1 | a Hung, Rayjean J.u Mount Sinai Hospital of University of Toronto4 aut |
700 | 1 | a Amos, Christopher I.u Dartmouth College4 aut |
700 | 1 | a McKay, Jamesu International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Brennan, Paulu International Agency for Research on Cancer, World Health Organization4 aut |
710 | 2 | a International Agency for Research on Cancer, World Health Organizationb University of Bristol4 org |
773 | 0 | t PLOS ONEd : Public library scienceg 12:6q 12:6x 1932-6203 |
856 | 4 | u https://doi.org/10.1371/journal.pone.0177875y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1120595/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0177875&type=printable |
856 | 4 | u http://dx.doi.org/10.1371/journal.pone.0177875x freey FULLTEXT |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-137383 |
856 | 4 8 | u https://doi.org/10.1371/journal.pone.0177875 |
856 | 4 8 | u https://lup.lub.lu.se/record/c57d2208-8a7c-4b90-a329-db261e03f196 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.